Search Count: 5
 |
Optimization Efforts For Identification Of Novel Highly Potent Keap1-Nrf2 Protein-Protein Interaction Ihhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.32 Å Release Date: 2024-05-22 Classification: PEPTIDE BINDING PROTEIN Ligands: A1LVB, ACT, SO4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-05-22
Ligands: A1LVB, ACT, SO4
 |
Optimization Efforts For Identification Of Novel Highly Potent Keap1-Nrf2 Protein-Protein Interaction (Ppi) Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.42 Å Release Date: 2024-05-22 Classification: PEPTIDE BINDING PROTEIN Ligands: A1LVC, ACT, SO4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-05-22
Ligands: A1LVC, ACT, SO4
 |
Methyl And Fluorine Effects In Novel Orally Bioavailable Keap1/Nrf2 Ppi Inhibitor For Treatment Of Chronic Kidney Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2023-06-14 Classification: PEPTIDE BINDING PROTEIN Ligands: SGO, DTT, SO4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-06-14
Ligands: SGO, DTT, SO4
 |
Methyl And Fluorine Effects In Novel Orally Bioavailable Keap1/Nrf2 Ppi Inhibitor For Treatment Of Chronic Kidney Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2023-06-14 Classification: PEPTIDE BINDING PROTEIN Ligands: SIU, SO4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-06-14
Ligands: SIU, SO4
 |
Methyl And Fluorine Effects In Novel Orally Bioavailable Keap1/Nrf2 Ppi Inhibitor For Treatment Of Chronic Kidney Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.48 Å Release Date: 2023-06-14 Classification: PEPTIDE BINDING PROTEIN Ligands: T6I, SO4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2023-06-14
Ligands: T6I, SO4